MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with I

Ibuprofen lysine

Ibuprofen lysine 342mg tablets

No stability information

Stability notes for Ibuprofen lysine 342mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Ibuprofen lysine 342mg tablets
Boots Migraine Pain Relief Ibuprofen lysine 342mg tablets (The Boots Company Plc)
Boots Rapid Ibuprofen lysine 342mg tablets (The Boots Company Plc)
Feminax Express 342mg tablets (Bayer Plc)
Galpharm Rapid Ibuprofen lysine 342mg tablets (Galpharm International Ltd)
Nurofen Migraine Pain 342mg caplets (Reckitt Benckiser Healthcare (UK) Ltd)

Ibuprofen lysine 684mg tablets

No stability information

Stability notes for Ibuprofen lysine 684mg tablets

There are no stability notes for this medicine.

Supplier

Nurofen Maximum Strength Migraine Pain 684mg caplets (Reckitt Benckiser Healthcare (UK) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.